We are live on ! Find out more
ASMB icon

Assembly Biosciences
ASMB

37 hedge funds and large institutions have $26.7M invested in Assembly Biosciences in 2013 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 7 increasing their positions, 10 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

4% more capital invested

Capital invested by funds: $25.6M → $26.7M (+$1.1M)

14% less funds holding

Funds holding: 43 → 37 (-6)

30% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 10

40% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 15

60% less call options, than puts

Call options by funds: $49K | Put options by funds: $121K

Holders
37
Holders Change
-6
Holders Change %
-13.95%
% of All Funds
1.2%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
7
Reduced
10
Closed
15
Calls
$49K
Puts
$121K
Net Calls
-$72K
Net Calls Change
-$26K

Top Buyers

1
DS
DRW Securities
Illinois
+$102K
2
BIT
BlackRock Institutional Trust
California
+$99.6K
3
FNYS
First New York Securities
New York
+$99.6K
4
Group One Trading
Group One Trading
Illinois
+$82K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$78K

Top Sellers

1
SM
Sabby Management
Florida
-$1.67M
2
SC
Sophrosyne Capital
New York
-$925K
3
Northern Trust
Northern Trust
Illinois
-$273K
4
Deutsche Bank
Deutsche Bank
Germany
-$246K
5
PP
Paloma Partners
Connecticut
-$203K
Name Holding Trade Value Shares
Change 		Change in
Stake
BC
1
Broadfin Capital
New York
$5.35M – – –
EM
2
Elliott Management
New York
$5.17M – – –
VAM
3
Visium Asset Management
New York
$4.33M – – –
BBA
4
Baker Bros. Advisors
New York
$3.51M – – –
TAM
5
THB Asset Management
Connecticut
$2.74M -$90.7K -592 -4%
Deutsche Bank
6
Deutsche Bank
Germany
$1.39M -$246K -1,605 -17%
BIT
7
BlackRock Institutional Trust
California
$1.01M +$99.6K +650 +13%
SC
8
Sophrosyne Capital
New York
$637K -$925K -6,038 -62%
Vanguard Group
9
Vanguard Group
Pennsylvania
$567K +$74.8K +488 +18%
Renaissance Technologies
10
Renaissance Technologies
New York
$381K -$151K -984 -31%
BFA
11
BlackRock Fund Advisors
California
$185K +$12.9K +84 +9%
California Public Employees Retirement System
12
California Public Employees Retirement System
California
$165K – – –
Geode Capital Management
13
Geode Capital Management
Massachusetts
$156K +$306 +2 +0.2%
DS
14
DRW Securities
Illinois
$117K +$102K +667 New
FNYS
15
First New York Securities
New York
$113K +$99.6K +650 New
Group One Trading
16
Group One Trading
Illinois
$109K +$82K +535 +575%
BRWA
17
B. Riley Wealth Advisors
Florida
$107K +$1.84K +12 +2%
Morgan Stanley
18
Morgan Stanley
New York
$96K -$25.4K -166 -23%
Susquehanna International Group
19
Susquehanna International Group
Pennsylvania
$88K +$78K +509 New
Northern Trust
20
Northern Trust
Illinois
$74K -$273K -1,783 -81%
SIM
21
Spark Investment Management
New York
$56K +$49.8K +325 New
WC
22
Woodstock Corp
Massachusetts
$49K – – –
State Street
23
State Street
Massachusetts
$45K -$10.7K -70 -21%
PPA
24
Parametric Portfolio Associates
Washington
$44K -$14.2K -93 -27%
BG
25
BlackRock Group
United Kingdom
$37K +$32.8K +214 New
1
2

ASMB Hedge Fund Activity: Q3 2013 in Review

37 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in Assembly Biosciences (ASMB) for Q3 2013, worth a combined $26.7M — up 4.3% from $25.6M a quarter earlier.

Sellers outnumbered buyers: 15 funds closed out of ASMB and 9 opened new positions — a net loss of 6 holders — while 10 trimmed existing stakes and 7 added.

The largest buyer was DRW Securities, opening a new position worth an estimated $102K. The largest seller was Sabby Management, exiting entirely with an estimated $1.67M sold.

  • 37 institutional investors held Assembly Biosciences (ASMB) as of Q3 2013, down from 43 in Q2 2013.
  • Funds reported $26.7M of Assembly Biosciences stock for Q3 2013, up 4.3% quarter-over-quarter.
  • 9 funds opened new Assembly Biosciences positions in Q3 2013 and 15 closed out, a net change of -6 holders.
  • The largest Assembly Biosciences buyer in Q3 2013 was DRW Securities, an estimated $102K added.
  • The largest Assembly Biosciences seller in Q3 2013 was Sabby Management, an estimated $1.67M sold.

Based on aggregated 13F filings for Q3 2013.